Friday, March 29, 2024
Home Tags Jounce

Tag: Jounce

Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021...

0
-Translational analysis of patients that do not respond to PD-(L)1 inhibitors show high pretreatment intratumoral LILRB2 expression relative to an IFNγ gene signature-...

Jounce Therapeutics Announces Pricing of $56.25 Million Public Offering of Common...

0
CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery and...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News